BD Adds Surveillance Capability to Infectious Disease Portfolio
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among patients and healthcare workers, and in the community.
Read More